Nectar Lifescience Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 281.02 | 430.77 | 455.56 |
| Operating Expense | 342.56 | 585 | 410.27 |
| Net Profit | -63.23 | -130.09 | 7.84 |
| Net Profit Margin | -22.50 | -30.20 | 1.72 |
| Earning Per Share | -2.82 | -5.80 | 0.35 |
| EBIDTA | -28.01 | -96.65 | 40.57 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 281.02 |
| Operating Expense | 342.56 |
| Net Profit | -63.23 |
| Net Profit Margin | -22.50 |
| Earning Per Share | -2.82 |
| EBIDTA | -28.01 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,669.97 | 1,684.09 | 1,523.67 |
| Operating Expenses Annual | 1,699.53 | 1,532.53 | 1,468.95 |
| Operating Profit Annual | -24.57 | 166.14 | 97.90 |
| Interest Annual | 74.58 | 87.14 | 79.48 |
| Depreciation | 62.39 | 60.72 | 59.12 |
| Net Profit Annual | -113.68 | 5.00 | -22.46 |
| Tax Annual | -47.85 | 13.27 | -18.24 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,669.97 |
| Operating Expenses Annual | 1,699.53 |
| Operating Profit Annual | -24.57 |
| Interest Annual | 74.58 |
| Depreciation | 62.39 |
| Net Profit Annual | -113.68 |
| Tax Annual | -47.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 19.80 | 17.57 | 17.74 |
| Cash Flow from Operations | 169.44 | 224.69 | 133.37 |
| Cash Flow from Investing | -41.93 | -17.03 | 52.03 |
| Cash Flow from Financing | -128.09 | -205.44 | -185.57 |
| Cash Flow at the End | 19.22 | 19.80 | 17.57 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 19.80 |
| Cash Flow from Operations | 169.44 |
| Cash Flow from Investing | -41.93 |
| Cash Flow from Financing | -128.09 |
| Cash Flow at the End | 19.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -1.29 | 8.63 | 3.29 |
| PBIT Margin (%) | -4.56 | 5.47 | -0.10 |
| PBT Margin (%) | -4.50 | 5.41 | -0.10 |
| Net PROFIT Margin (%) | -5.96 | 0.26 | -1.29 |
| Return On Networth / Equity (%) | -11.23 | 0.47 | -5.85 |
| Return On Networth /Employed (%) | -5.33 | 5.96 | -0.09 |
| Return On Assets (%) | -6.97 | 0.28 | -1.18 |
| Total Debt / Equity (X) | 0.60 | 0.65 | 0.75 |
| Asset Turnover Ratio (%) | 1.17 | 1.09 | 0.92 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -1.29 |
| PBIT Margin (%) | -4.56 |
| PBT Margin (%) | -4.50 |
| Net PROFIT Margin (%) | -5.96 |
| Return On Networth / Equity (%) | -11.23 |
| Return On Networth /Employed (%) | -5.33 |
| Return On Assets (%) | -6.97 |
| Total Debt / Equity (X) | 0.60 |
| Asset Turnover Ratio (%) | 1.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 633.11 | 642.71 | 661.97 |
| Total Current Assets Annual | 1,237.58 | 1,283.83 | 1,231.17 |
| Non Current Assets Annual | 809.65 | 907.23 | 958.04 |
| Total Shareholders Funds Annual | 956.11 | 1,069.25 | 1,064.60 |
| Total Assets Annual | 2,047.23 | 2,191.06 | 2,189.21 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 633.11 |
| Total Current Assets Annual | 1,237.58 |
| Non Current Assets Annual | 809.65 |
| Total Shareholders Funds Annual | 956.11 |
| Total Assets Annual | 2,047.23 |
EPS (INR)
Expected
0.00
Reported
-2.82
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
